Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2015-04-16

FDA Approved: PRIMAQUINE PHOSPHATE — Supplemental Application (Sanofi-Aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for Primaquine phosphate submitted by Sanofi-Aventis U.S. LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PRIMAQUINE PHOSPHATE (primaquine phosphate)

Snippet

SUPPL AP for PRIMAQUINE PHOSPHATE (PRIMAQUINE PHOSPHATE)